Search

Your search keyword '"Gattorno, M"' showing total 47 results

Search Constraints

Start Over You searched for: Author "Gattorno, M" Remove constraint Author: "Gattorno, M" Topic familial mediterranean fever Remove constraint Topic: familial mediterranean fever
47 results on '"Gattorno, M"'

Search Results

1. Reliability of a generative artificial intelligence tool for pediatric familial Mediterranean fever: insights from a multicentre expert survey.

2. Pyrin Inflammasome Activation Defines Colchicine-Responsive SURF Patients from FMF and Other Recurrent Fevers.

3. The pyrin inflammasome, a leading actor in pediatric autoinflammatory diseases.

4. Complex regulation of alarmins S100A8/A9 and secretion via gasdermin D pores exacerbates autoinflammation in familial Mediterranean fever.

5. An Update on Familial Mediterranean Fever.

6. The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort.

7. Defining colchicine resistance/intolerance in patients with familial Mediterranean fever: a modified-Delphi consensus approach.

8. Persistence of disease flares is associated with an inadequate colchicine dose in familial Mediterranean fever: A national multicenter longitudinal study.

9. PAPA and FMF in two siblings: possible amplification of clinical presentation? A case report.

10. An International Delphi Survey for the Definition of New Classification Criteria for Familial Mediterranean Fever, Mevalonate Kinase Deficiency, TNF Receptor-associated Periodic Fever Syndromes, and Cryopyrin-associated Periodic Syndrome.

11. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.

12. Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome.

13. Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study.

14. A novel assessment tool for clinical care of patients with autoinflammatory disease: juvenile autoinflammatory disease multidimensional assessment report.

15. Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF).

16. EULAR recommendations for the management of familial Mediterranean fever.

17. Performance of Different Diagnostic Criteria for Familial Mediterranean Fever in Children with Periodic Fevers: Results from a Multicenter International Registry.

18. Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever.

19. International periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome cohort: description of distinct phenotypes in 301 patients.

20. Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children.

21. Increased NLRP3-dependent interleukin 1β secretion in patients with familial Mediterranean fever: correlation with MEFV genotype.

22. Beyond the NLRP3 inflammasome: autoinflammatory diseases reach adolescence.

23. Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review.

24. Clinical impact of MEFV mutations in children with periodic fever in a prevalent western European Caucasian population.

25. Candidate genes in patients with autoinflammatory syndrome resembling tumor necrosis factor receptor-associated periodic syndrome without mutations in the TNFRSF1A gene.

26. Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene.

27. The 423Q polymorphism of the X-linked inhibitor of apoptosis gene influences monocyte function and is associated with periodic fever.

28. Differentiating PFAPA syndrome from monogenic periodic fevers.

29. A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children.

30. Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome.

31. Diagnosis and management of autoinflammatory diseases in childhood.

32. MVK mutations and associated clinical features in Italian patients affected with autoinflammatory disorders and recurrent fever.

33. Performance of Different Diagnostic Criteria for Familial Mediterranean Fever in Children with Periodic Fevers: Results from a Multicenter International Registry

34. Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers

35. Development of the autoinflammatory disease damage index (ADDI)

36. An international registry on autoinflammatory diseases: the Eurofever experience

37. Persistence of disease flares is associated with an inadequate colchicine dose in familial Mediterranean fever: A national multicenter longitudinal study

38. MVK mutations and associated clinical features in Italian patients affected with autoinflammatory disorders and recurrent fever

39. The impact of the Eurofever criteria and the new Infevers MEFV classification in real life: results from a large international FMF cohort

40. A web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry

41. Next-generation sequencing and its initial applications for molecular diagnosis of systemic auto-inflammatory diseases

42. Differentiating PFAPA Syndrome From Monogenic Periodic Fevers

43. Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review

44. Clinical impact of MEFV mutations in children with periodic fever in a prevalent western European Caucasian population

45. Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene

46. A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children

47. Follow-Up and Quality of Life of Patients with Cryopyrin-Associated Periodic Syndromes Treated with Anakinra

Catalog

Books, media, physical & digital resources